Khoso Baluch - 27 Jun 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Khoso Baluch by Neda Sharifi, as Attorney-in-fact
Issuer symbol
PCSA
Transactions as of
27 Jun 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 18:29:49 UTC
Previous filing
12 Jun 2023
Next filing
26 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +15,455 +124% 27,955 27 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Options Exercise $0 -15,455 -100% $0.000000* 0 27 Jun 2023 Common Stock 15,455 $0.000000 Direct F1
transaction PCSA Restricted Stock Award $0 +101,365 $0.000000 101,365 27 Jun 2023 Common Stock 101,365 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.